Lilly's Weight-Loss Pill Outsells Wegovy By Volume, Not Revenue
Foundayo is growing, Wegovy is enormous, and the cheap starter dose is turning a miracle-drug boom into a margin argument.
Nora Whitfield
Bureau: Chicago
Three Health Stories, One Hidden Variable — Public Trust
Measles, CDC vaccine language, and GLP-1 affordability are three versions of one problem, medicine asking people to trust systems they cannot audit.
Britain's Drug Watchdog Reopens Alzheimer's Decision On Caregiver Costs
The NICE appeals move the Alzheimer's drug fight from miracle-versus-cost into the economics of carers, infusion time, and unpaid work.
Utah Reports 638 Measles Cases, Endangering U.S. Elimination Status
Utah's 638-case measles outbreak is now a November elimination-status story and a vaccine-trust story at once.
H5N1 Dairy Testing Underpins The Idaho Outbreak Watch
Idaho's unresolved H5N1 vector question depends on the milk-testing machinery that decides what investigators can see.
CDC's Autism Page Becomes A Test Of Vaccine Trust
The CDC autism page is not only a wording fight when a Science experiment can measure lower vaccine intent.
Eugene Braunwald Memorial Fund Will Carry On His Mentorship
Braunwald's AHA memorial page makes his legacy a funding and mentorship program, not only a great-man obituary.